Recombinant Thrombomodulin
Recombinant Thrombomodulin is a biopharmaceutical agent belonging to the class of anticoagulant proteins, distinguished by its engineered production through recombinant DNA technology to replicate the functional domains of human thrombomodulin for modulating coagulation and inflammation in disseminated intravascular coagulation.
296
Publications
14K
Citations
1.7K
Authors
472
Institutions
Publications per year
2017–2026
63
Variants
Art-123Thrombomodulin Alfa
296
Hiroaki Saito, Ikuro Maruyama, S Shimazaki et al. · Journal of Thrombosis and Haemostasis · 2006 · 600 citations
Medicine, Hematology, Pharmacology +11
Saulius Butenas, Cornelis van’t Veer, Kenneth G. Mann · Blood · 1999 · 381 citations
Medicine, Biochemistry, Hematology +17
1–5 of 296
1.7K
18
h-index
13
h-index
13
h-index
12
h-index
11
h-index
1–5 of 1.7K
472
Asahi Kasei (Japan)
Tokyo, Japan
19 h-index
61 publications
3.4K citations

Kagoshima University
Kagoshima, Japan
18 h-index
58 publications
4.7K citations

Howard Hughes Medical Institute
Chevy Chase, United States
14 h-index
45 publications
3.1K citations
Eli Lilly (United States)
Indianapolis, United States
12 h-index
36 publications
1.7K citations
Oklahoma Medical Research Foundation
Oklahoma City, United States
12 h-index
29 publications
1.8K citations
The University of Osaka
Osaka, Japan
12 h-index
54 publications
3.1K citations
Tokyo Medical and Dental University
Tokyo, Japan
11 h-index
28 publications
1.5K citations

Tohoku University
Sendai, Japan
10 h-index
44 publications
1.4K citations
1–8 of 472
JBC · 24 publications · 1.8K citations
23
h-index
19 publications · 864 citations
16
h-index
13 publications · 371 citations
12
h-index
CATH · 7 publications · 166 citations
7
h-index
7 publications · 465 citations
7
h-index
1–5